The cost-utility of adjuvant chemotherapy using docetaxel and cyclophosphamide compared with doxorubicin and cyclophosphamide in breast cancer

Tallal Younis, D. Rayson, C. Skedgel

Research output: Contribution to journal › Article › peer-review

25 Citations (Scopus)

Fingerprint

Dive into the research topics of 'The cost-utility of adjuvant chemotherapy using docetaxel and cyclophosphamide compared with doxorubicin and cyclophosphamide in breast cancer'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science